The global diabetes management devices market is expected to grow from $9bn in 2015 to $11.2bn by 2020, a CAGR of 4.5%. While blood glucose monitors – continuous or otherwise –account for the largest product segment of the total diabetes market with about 66% of total sales, the smaller, yet highly innovative insulin pump segment is expected to see the biggest growth.
According to a new report by Meddevicetracker, "Global Diabetes Management Devices Market," global sales of glucose meters and CGMs are expected to rise from roughly $6bn in 2015 to $7bn in 2020, a CAGR of 3.2%. This is driven partly by the vast majority of both Type 1 and Type 2 diabetics using these devices as an integral part of their daily glucose monitoring routine, compared to a smaller number of severe Type 1 diabetics having to rely on insulin pumps
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?